Houston, TX -- (SBWIRE) -- 02/06/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Merck & Co., Inc. (NYSE:MRK) fell 0.84% and is trading at $41.08. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Can MRK Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Boston Scientific Corporation (NYSE:BSX) is lower 0.91% and is trading at $7.60. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology.
How Should Investors Trade BSX After The Recent Volatile Moves? Find Out Here
Pfizer Inc. (NYSE:PFE) fell 0.43% and is trading at $27.39 Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.
Is PFE Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
Abbott Laboratories (NYSE:ABT) added 0.47% and is trading at $34.00. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products.
Can ABT Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Hologic, Inc. (NASDAQ:HOLX) is lower 1.36% and is trading at $22.44. Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health.
Is HOLX Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)